Global Access to Lifesaving Therapies
Facilitating patient reach to FDA and EMA approved medicines regulated under legal frameworks
- Access to Global Medicines
- Regulatory-Compliant Imports
- Fast, Reliable Delivery
- Trusted by Leading Doctors
- No Hidden Charges
- Experts in Rare & Orphan Drugs
- Secure Cold-Chain Delivery
- Patient-Centric & Ethical
Our Services
MitoGENE NPP™ – Named Patient Program Services
MitoGENE provides Named Patient Program (NPP) services in India, helping patients access medicines that may not be commercially available locally. We coordinate with treating physicians and international pharmaceutical suppliers to support prescription documentation, regulatory requirements, medicine sourcing, importation, customs clearance, and delivery through applicable legal pathways.
MitoGENE MAP™ – Managed Access Programs & Real-World Evidence
MitoGENE MAP™ helps pharmaceutical and biotechnology companies manage patient access programs in India, from early and expanded access to pre-launch and post-approval access. We coordinate program operations, patient access, medicine supply, and structured real-world data collection to support better visibility into treatment patterns and patient journeys.
MitoGENE CTrial™ – Clinical Trial Supply Services
MitoGENE CTrial™ provides clinical trial supply services in India, supporting pharmaceutical companies, biotechnology firms, and CROs with investigational medicines, comparator products, import coordination, customs clearance, and temperature-controlled logistics. We coordinate clinical trial supplies from international sourcing to delivery at designated trial sites, with a focus on timely execution and shipment traceability.
Who We Serve
Patients & Physicians
Through Named Patient Program (NPP) we help patients legally access medicines unavailable in India through the Named Patient Import framework.
Patients: We guide individuals and families in accessing unapproved medicines for serious or rare conditions.
Physicians: We support doctors with required documentation and regulatory clarity for prescribing NPP medicines.
Hospitals, Clinics & Distributors
We supply WHO-GMP & GDP complaint Finished Formulations to healthcare institutions and licensed distributors globally.
Distributors: We work with licensed partners to deliver specialty medicines to markets with limited access.
Hospitals & Clinics: We provide quality formulations for critical care across key therapeutic areas.
Manufacturers, CMOs & R&D
We source high-purity APIs from certified Indian producers to support manufacturing and research.
R&D Institutions: Specialty and rare APIs available in flexible quantities for research needs
Manufacturers: Access compliant APIs for scalable, cost-effective production.
CMOs: Reliable sourcing with documentation for smooth regulatory compliance.
“We’re driven by purpose – to empower healthcare and research ecosystems with ethical, effective solutions”
Featured Products
Retsevmo
Daurismo
Pemazyre
ORSERDU
COLUMVI
Talvey
LUMYKRAS
Ninlaro
Lytgobi
Tukysa
Testimonials
“When we were struggling to access Nerlynx in Chennai, MitoGENE responded within hours of our inquiry. They explained the process clearly, quoted a fair price, and ensured timely delivery.”
By Mrs. Rekha S. – Chennai (Breast Cancer – Nerlynx)
“We had contacted several providers for Retsvemo, but MitoGENE stood out for their transparency and efficiency and fair pricing. The medicine reached us in less than a week, perfectly packed. Their updates via WhatsApp gave us peace of mind.”
By Mr. Arvind Kumar – Bangalore (Lung Cancer – Retsvemo)
“Accessing Onivyde in Hyderabad was a challenge until MitoGENE stepped in. They guided us through the import process with utmost care. Pricing was very reasonable and there were no hidden costs. Highly professional and empathetic team.”
By Mrs. Latha B. – Hyderabad (Pancreatic Cancer – Onivyde)
“From application to customs clearance, MitoGENE handled everything efficiently. They kept our family informed at every stage. The cold-chain delivery was intact even in the Chennai heat.”
By Mr. Ramesh P. – Chennai (Meyloma – Talvey)
“I had doubts about ordering imported oncology drugs, but MitoGENE’s clarity and documentation gave us confidence. The medicine was delivered safely, temperature logs included. No hassle, no delay. It reached just in time for my mother’s next cycle.”
By Mrs. Deepika J. – Bangalore (Cholangiocarcinoma – Pemazyre)
“Excellent service and personal attention! Their team even coordinated with our oncologist to get the prescription in proper formt. The shipment arrived faster than we expected and was priced better than other quotes we received.”
By Mr. N. Srinivas – Hyderabad (Bladder Cancer – Padcev)
“We needed Lysodren urgently. MitoGENE not only sourced it. The entire process was stress-free, and their follow-up post-delivery was thoughtful.”
By Mrs. Aarthi K. – Chennai (Adrenal Cancer – Lysodren)
Thanks to MitoGENE for helping us in sourcing the Retsevmo medicine from Germany for my Father. The entire process was clearly explained and we got guidance at every step, leading to seamless and predictable transaction.Happy to give recommendation to other customers
By Mr. Kumar – AVP, Cognizant, Chennai (Lung Cancer – Retsvemo)
“MitoGENE’s support team is responsive even during weekends. The pricing was transparent from day one, and all import documentation was handled professionally. The drug was shipped to our Mumbai address on time with zero damage.”
By Mr. Rajeev Menon – Mumbai (Liver Cancer – Stivarga)
“We faced delays with other providers, but MitoGENE processed our request within 24 hours and shipped Columvi in a temperature-controlled pack. Customs clearance was smooth thanks to their documentation support.”
By Mr. K. Vijay – Hyderabad (Diffuse Large B-Cell Lymphoma – Columvi)
“We chose MitoGENE after researching online, and I’m glad we did. Their NPP team handled our case urgently, coordinated with the hospital, and ensured the medication arrived securely within 6 days. Great support and empathy.”
By Ms. Preeti S. – Bangalore (Platinum-Resistant Ovarian Cancer – Elahere)